Why the product labeling for low-dose vaginal estrogen should be changed

Menopause. 2014 Sep;21(9):911-6. doi: 10.1097/GME.0000000000000316.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Intravaginal
  • Atrophy
  • Estrogen Replacement Therapy
  • Estrogens / administration & dosage*
  • Female
  • Humans
  • Postmenopause*
  • Product Labeling*
  • Vagina / pathology

Substances

  • Estrogens